Pruritus Treatment Pipeline Review H2 2016

PUNE, INDIA, January 6, 2017 /EINPresswire.com/ -- GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/822688-pruritus-pipeline-review-h2-2016

‘Pruritus - Pipeline Review, H2 2016’, provides an overview of the Pruritus pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Pruritus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects.
Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
The report provides a snapshot of the global therapeutic landscape of Pruritus
The report reviews pipeline therapeutics for Pruritus by companies and universities/research institutes based on information derived from company and industry-specific sources
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved Pruritus therapeutics and enlists all their major and minor projects
The report assesses Pruritus therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news related to pipeline therapeutics for Pruritus

Reasons to Buy
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Pruritus
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Pruritus pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Pruritus Overview 10
Therapeutics Development 11
Pipeline Products for Pruritus - Overview 11
Pipeline Products for Pruritus - Comparative Analysis 12
Pruritus - Therapeutics under Development by Companies 13
Pruritus - Therapeutics under Investigation by Universities/Institutes 15
Pruritus - Pipeline Products Glance 16
Late Stage Products 16
Clinical Stage Products 17
Early Stage Products 18
Pruritus - Products under Development by Companies 19
Pruritus - Products under Investigation by Universities/Institutes 21
Pruritus - Companies Involved in Therapeutics Development 22
Albireo AB 22
Alveonix AG 23
Amorepacific Corporation 24
Asana BioSciences, LLC 25
Cara Therapeutics, Inc. 26
Chugai Pharmaceutical Co., Ltd. 27
Creabilis SA 28
ELORAC, Inc. 29
Faes Farma, S.A. 30
GlaxoSmithKline Plc 31
Hydra Biosciences, Inc. 32
LEO Pharma A/S 33
Merck & Co., Inc. 34
NeRRe Therapeutics Ltd 35
Nippon Shinyaku Co., Ltd. 36
Patara Pharma, Inc. 37
Phosphagenics Limited 38
RDD Pharma Ltd. 39
Sanwa Kagaku Kenkyusho Co., Ltd. 40
…Continued
ACCESS REPORT @ https://www.wiseguyreports.com/reports/822688-pruritus-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here